A half century of γ-aminobutyric acid
- PMID: 32166183
- PMCID: PMC7058221
- DOI: 10.1177/2398212819858249
A half century of γ-aminobutyric acid
Abstract
γ-aminobutyric acid has become one of the most widely known neurotransmitter molecules in the brain over the last 50 years, recognised for its pivotal role in inhibiting neural excitability. It emerged from studies of crustacean muscle and neurons before its significance to the mammalian nervous system was appreciated. Now, after five decades of investigation, we know that most neurons are γ-aminobutyric-acid-sensitive, it is a cornerstone of neural physiology and dysfunction to γ-aminobutyric acid signalling is increasingly documented in a range of neurological diseases. In this review, we briefly chart the neurodevelopment of γ-aminobutyric acid and its two major receptor subtypes: the γ-aminobutyric acidA and γ-aminobutyric acidB receptors, starting from the humble invertebrate origins of being an 'interesting molecule' acting at a single γ-aminobutyric acid receptor type, to one of the brain's most important neurochemical components and vital drug targets for major therapeutic classes of drugs. We document the period of molecular cloning and the explosive influence this had on the field of neuroscience and pharmacology up to the present day and the production of atomic γ-aminobutyric acidA and γ-aminobutyric acidB receptor structures. γ-Aminobutyric acid is no longer a humble molecule but the instigator of rich and powerful signalling processes that are absolutely vital for healthy brain function.
Keywords: GABA; GABAA receptor; GABAB receptor; inhibition.
© The Author(s) 2019.
Conflict of interest statement
Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures





Similar articles
-
Characterization of bicuculline/baclofen-insensitive (rho-like) gamma-aminobutyric acid receptors expressed in Xenopus oocytes. II. Pharmacology of gamma-aminobutyric acidA and gamma-aminobutyric acidB receptor agonists and antagonists.Mol Pharmacol. 1993 Apr;43(4):609-25. Mol Pharmacol. 1993. PMID: 8386310
-
Analysis of gamma-aminobutyric acidB receptor function in the in vitro and in vivo regulation of alpha-melanotropin-stimulating hormone secretion from melanotrope cells of Xenopus laevis.Endocrinology. 1993 Feb;132(2):674-81. doi: 10.1210/endo.132.2.8381070. Endocrinology. 1993. PMID: 8381070
-
Gamma-aminobutyric acidB, but not gamma-aminobutyric acidA receptor activation, inhibits electrically evoked substance P-like immunoreactivity release from the rat spinal cord in vitro.J Pharmacol Exp Ther. 1993 Sep;266(3):1490-6. J Pharmacol Exp Ther. 1993. PMID: 7690402
-
Gamma-aminobutyric acidA receptor subunits in the mediation of selective drug action.Curr Opin Neurol Neurosurg. 1993 Aug;6(4):597-601. Curr Opin Neurol Neurosurg. 1993. PMID: 8104553 Review.
-
[Pharmacology and physiological function of gamma-aminobutyric acid B type receptor].Nihon Yakurigaku Zasshi. 1991 Apr;97(4):179-89. doi: 10.1254/fpj.97.4_179. Nihon Yakurigaku Zasshi. 1991. PMID: 1651889 Review. Japanese.
Cited by
-
Pharmacotherapy of Alzheimer's disease: an overview of systematic reviews.Eur J Clin Pharmacol. 2022 Oct;78(10):1567-1587. doi: 10.1007/s00228-022-03363-6. Epub 2022 Jul 26. Eur J Clin Pharmacol. 2022. PMID: 35881170 Review.
-
Looking for Novelty in an "Old" Receptor: Recent Advances Toward Our Understanding of GABAARs and Their Implications in Receptor Pharmacology.Front Neurosci. 2021 Jan 14;14:616298. doi: 10.3389/fnins.2020.616298. eCollection 2020. Front Neurosci. 2021. PMID: 33519367 Free PMC article. Review.
-
Cryo-EM as a powerful tool for drug discovery.Bioorg Med Chem Lett. 2020 Nov 15;30(22):127524. doi: 10.1016/j.bmcl.2020.127524. Epub 2020 Sep 2. Bioorg Med Chem Lett. 2020. PMID: 32890683 Free PMC article. Review.
-
Molecular Changes in the Brain of the Wintering Calidris pusilla in the Mangroves of the Amazon River Estuary.Int J Mol Sci. 2023 Aug 12;24(16):12712. doi: 10.3390/ijms241612712. Int J Mol Sci. 2023. PMID: 37628893 Free PMC article.
-
γ-aminobutyric acid B2 receptor: A potential therapeutic target for cholangiocarcinoma in patients with diabetes mellitus.World J Gastroenterol. 2023 Jul 28;29(28):4416-4432. doi: 10.3748/wjg.v29.i28.4416. World J Gastroenterol. 2023. PMID: 37576707 Free PMC article.
References
-
- Barber RP, Vaughn JE, Saito K, et al. (1978) GABAergic terminals are presynaptic to primary afferent terminals in the substantia gelatinosa of the rat spinal cord. Brain Research 141(1): 35–55. - PubMed
-
- Barnard EA, Darlison MG, Seeburg P. (1987) Molecular biology of the GABAA receptor: The receptor/channel super-family. Trends in Neurosciences 10(12): 502–509.
-
- Beaumont K, Chilton WS, Yamamura HI, et al. (1978) Muscimol binding in rat brain: Association with synaptic GABA receptors. Brain Research 148(1): 153–162. - PubMed
-
- Ben Ari Y. (2002) Excitatory actions of GABA during development: The nature of the nurture. Nature Reviews: Neuroscience 3(9): 728–739. - PubMed
-
- Ben Ari Y, Gaiarsa JL, Tyzio R, et al. (2007) GABA: A pioneer transmitter that excites immature neurons and generates primitive oscillations. Physiological Reviews 87(4): 1215–1284. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources